These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review. Kaida K; Kusunoki S J Neuroimmunol; 2010 Jun; 223(1-2):5-12. PubMed ID: 20172612 [TBL] [Abstract][Full Text] [Related]
3. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234 [TBL] [Abstract][Full Text] [Related]
4. [Guillain-Barré and Fisher syndromes: update on the pathophysiological role of antiganglioside antibodies]. Kaida K Rinsho Shinkeigaku; 2012; 52(11):914-6. PubMed ID: 23196466 [TBL] [Abstract][Full Text] [Related]
5. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders. Kusunoki S; Kaida K J Neurochem; 2011 Mar; 116(5):828-32. PubMed ID: 21214559 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes. Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994 [TBL] [Abstract][Full Text] [Related]
7. [Antiganglioside antibodies: when, which and for what]. Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721 [TBL] [Abstract][Full Text] [Related]
8. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes. Kanzaki M; Kaida K; Ueda M; Morita D; Hirakawa M; Motoyoshi K; Kamakura K; Kusunoki S J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1148-52. PubMed ID: 18339728 [TBL] [Abstract][Full Text] [Related]
10. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies]. Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060 [TBL] [Abstract][Full Text] [Related]
11. Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions. Shahrizaila N; Yuki N Expert Rev Neurother; 2011 Sep; 11(9):1305-13. PubMed ID: 21864076 [TBL] [Abstract][Full Text] [Related]
12. [Antiganglioside antibodies--their pathophysiological effects on Guillain-Barré syndrome and variants]. Kaida K; Kusunoki S Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(1):29-39. PubMed ID: 21372511 [TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies. Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437 [TBL] [Abstract][Full Text] [Related]
14. Anti-ganglioside antibody and neuropathy: review of our research. Yuki N J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233 [TBL] [Abstract][Full Text] [Related]
15. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome. Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484 [TBL] [Abstract][Full Text] [Related]
16. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies. Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485 [TBL] [Abstract][Full Text] [Related]
17. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome. Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966 [TBL] [Abstract][Full Text] [Related]
18. The immunobiology of Guillain-Barré syndromes. Willison HJ J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123 [TBL] [Abstract][Full Text] [Related]
19. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes]. Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515 [TBL] [Abstract][Full Text] [Related]
20. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies. Nobile-Orazio E; Giannotta C; Briani C J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]